Simcere Pharmaceutical Group Limited — Capital/Financing Update 2020

Oct 13, 2020

GLOBAL OFFERING

	Simcere Pharmaceutical Group Limited (02096)

 

►	Cover
►	Important
►	Expected Timetable
►	Contents
►	Summary
►	Definitions
►	Glossary of Technical Terms
►	Forward-Looking Statements
►	Risk Factors
►	Waivers from Strict Compliance with the Listing Rules
►	Information about this Prospectus and the Global Offering
►	Directors and Parties Involved in the Global Offering
►	Corporate Information
►	Industry Overview
►	Regulatory Overview
►	History, Reorganization and Corporate Structure
►	Contractual Arrangements
►	Business
►	Connected Transactions
►	Relationship with Our Controlling Shareholders
►	Directors and Senior Management
►	Substantial Shareholders
►	Share Capital
►	Financial Information
►	Cornerstone Investors
►	Future Plans and Use of Proceeds
►	Underwriting
►	Structure of the Global Offering
►	How to Apply for the Hong Kong Offer Shares
►	Appendix I - Accountants' Report
►	Appendix II - Unaudited Pro Forma Financial Information
►	Appendix III - Profit Forecast
►	Appendix IV - Summary of Articles of Association
►	Appendix V - Statutory and General Information
►	Appendix VI - Documents Delivered to the Registrar of Companies and Available for Inspection
►	Back Cover